Coherus Oncology, Inc.
CHRS
$1.58
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.62% | 96.20% | 49.23% | -68.28% | 7.00% |
| Total Receivables | -84.94% | 26.00% | -61.85% | -78.03% | -53.04% |
| Inventory | -24.60% | -95.70% | -92.74% | -94.32% | -93.28% |
| Prepaid Expenses | -23.02% | -32.72% | -19.79% | 5.83% | -51.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -39.49% | 24.91% | -31.85% | -50.57% | -28.18% |
|
|
|||||
| Total Current Assets | -39.49% | 24.91% | -31.85% | -50.57% | -28.18% |
| Net Property, Plant & Equipment | -39.41% | -43.90% | -42.80% | -46.13% | -35.69% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -13.81% | -8.89% | -5.67% | -7.22% | -24.15% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -97.62% | -94.35% | -91.33% | -92.44% | -35.16% |
| Total Assets | -42.40% | 2.28% | -34.88% | -51.40% | -28.76% |
|
|
|||||
| Total Accounts Payable | -65.16% | 13.70% | -51.02% | 6.90% | -19.20% |
| Total Accrued Expenses | -72.00% | -59.61% | -49.75% | -36.41% | -22.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -35.61% | -52.98% | -57.36% | -98.98% | 32.35% |
| Total Finance Division Other Current Liabilities | 164.00% | 492.70% | -27.14% | -14.35% | 646.85% |
| Total Other Current Liabilities | 164.00% | 492.70% | -27.14% | -14.35% | 646.85% |
| Total Current Liabilities | -50.39% | 25.96% | -43.06% | -52.62% | -14.71% |
|
|
|||||
| Total Current Liabilities | -50.39% | 25.96% | -43.06% | -52.62% | -14.71% |
| Long-Term Debt | -82.54% | -82.67% | -82.77% | -1.61% | -38.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -55.66% | -47.93% | -42.23% | -39.02% | -38.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 154.15% | 126.01% | 109.57% | -34.64% | -86.20% |
| Total Liabilities | -66.01% | -27.70% | -57.89% | -34.40% | -29.47% |
|
|
|||||
| Common Stock & APIC | 1.75% | 1.47% | 1.72% | 2.10% | 2.38% |
| Retained Earnings | 10.83% | 10.33% | 12.07% | -8.87% | 1.80% |
| Treasury Stock & Other | 29.09% | 26.18% | -1.10% | -1.10% | -10.89% |
| Total Common Equity | 146.23% | 199.77% | 242.47% | -124.17% | 31.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 146.23% | 199.77% | 242.47% | -124.17% | 31.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 146.23% | 199.77% | 242.47% | -124.17% | 31.76% |
|
|
|||||